葛兰，重启限购

Group 1 - On August 9, China Europe Fund announced purchase limits for its funds managed by renowned fund managers, with a limit of 100,000 yuan for the China Europe Medical Innovation Fund and 1,000,000 yuan for the China Europe Science and Technology Theme Fund [1][3] - Approximately 50 actively managed equity funds have issued purchase limit announcements since July, including several high-performing products with significant returns over the past year [1][3][4] - The China Europe Medical Innovation Fund has achieved a return of over 80% in the past year, while the China Europe Science and Technology Theme Fund has seen a return of 84% as of August 8 [3][4] Group 2 - Industry experts suggest that the A-share market is expected to experience a gradual upward trend in the medium to long term, driven by increasing potential catalysts [6][5] - Allianz Fund's research department anticipates that the market will continue its upward trend in the third quarter, with a new cycle of value reassessment in the A-share market [6][5] - The third quarter is expected to see accelerated fundamentals in the technology sector, with high-quality technology assets likely to yield significant excess returns [6][5][7]